scholarly article | Q13442814 |
P356 | DOI | 10.1002/ART.1780130204 |
P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1780130204 |
https://onlinelibrary.wiley.com/doi/full/10.1002/art.1780130204 | ||
P698 | PubMed publication ID | 5421722 |
P2093 | author name string | A. S. Kraus | |
J. Uddin | |||
H. G. Kelly | |||
P2860 | cites work | Acta medica Scandinavica | Q10400528 |
Bulletin on the rheumatic diseases | Q27710130 | ||
COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT. | Q33626235 | ||
OBSERVATIONS ON THE CLINICAL, CHEMICAL, AND SEROLOGICAL MANIFESTATIONS OF RHEUMATOID ARTHRITIS, BASED ON THE COURSE OF 154 CASES | Q35423774 | ||
Variations in the course of rheumatoid arthritis | Q41354000 | ||
Rheumatoid arthritis: types of course and prognosis. | Q43943574 | ||
SYSTEMIC LUPUS ERYTHEMATOSUS. A STATISTICAL EVALUATION OF MORTALITY BASED ON A CONSECUTIVE SERIES OF 299 PATIENTS. | Q46604584 | ||
Survivorship in systemic lupus erythematosus: relationship to race and pregnancy | Q72370653 | ||
Length of life and cause of death in rheumatoid arthritis | Q73268669 | ||
Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus | Q73723971 | ||
The clinical features of rheumatoid arthritis. Prognostic indices | Q79058923 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunology | Q101929 |
rheumatoid arthritis | Q187255 | ||
rheumatology | Q327657 | ||
P304 | page(s) | 125-130 | |
P577 | publication date | 1970-03-01 | |
P1433 | published in | Arthritis and Rheumatism | Q23929027 |
P1476 | title | Survivorship and death in rheumatoid arthritis | |
Survivorship and Death in Rheumatoid Arthritis | |||
P478 | volume | 13 |
Q35609808 | Abnormal directed migration of blood polymorphonuclear leukocytes in rheumatoid arthritis. Potential role in increased susceptibility to bacterial infections |
Q35188551 | Acute and probable chronic Q fever during anti-TNFα and anti B-cell immunotherapy: a case report. |
Q33561006 | Australian mortality statistics for rheumatoid arthritis 1950-81: analysis of death certificate data |
Q88865461 | B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti-TNF-α Agents on B Lymphocytes: A Review of the Literature |
Q33552918 | Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis |
Q41117952 | Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine |
Q34067442 | Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis |
Q34309757 | Combination therapy: the risks of infection and tumor induction |
Q41157126 | Coronary arteritis complicating rheumatoid arthritis |
Q41959728 | Corticosteroids in rheumatoid arthritis |
Q42139986 | Death Rate and Causes of Death in Patients with Rheumatoid Arthritis |
Q39701538 | Epidemiological, sociological and environmental aspects of rheumatoid arthritis and osteoarthrosis |
Q33561343 | Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study |
Q39316868 | Gamma globulin complexes in rheumatoid pericardial fluid |
Q39540992 | Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis |
Q44204294 | Increased Mortality Among Persons with Rheumatoid Arthritis, But Where RA Does Not Appear on Death Certificate:Eleven-Year Follow-Up of an Epidemiological Study |
Q68094980 | Long-term effects of treating rheumatoid arthritis |
Q41913707 | Long-term outcome of treating rheumatoid arthritis: results after 20 years |
Q40640205 | Malignancy in Rheumatic Disease: Interrelationships |
Q34395747 | Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia |
Q33562682 | Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients |
Q33556875 | Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis |
Q35554834 | Mortality of rheumatoid arthritis in Japan: a longitudinal cohort study |
Q40218403 | Musculoskeletal syndromes associated with malignancy |
Q39644827 | Neoplastic associations of rheumatic diseases and rheumatic manifestations of cancer. |
Q36647506 | Pathogenesis of rheumatoid arthritis: its relevance to therapy in the '90s |
Q39787016 | Polyarthritis: The differential diagnosis of rheumatoid arthritis |
Q51846589 | Postoperative wound infection in rheumatoid arthritis surgery. |
Q36721210 | Pyogenic infection and rheumatoid arthritis |
Q33554467 | Rheumatoid arthritis in Lesotho |
Q43315904 | Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis |
Q92646829 | Soluble Markers of Antibody Secreting Cell Function as Predictors of Infection Risk in Rheumatoid Arthritis |
Q34485318 | Ten year mortality and causes of death in patients with rheumatoid arthritis |
Q72569860 | The economic impact of musculoskeletal disorders |
Q70426602 | The long-term effects of treating rheumatoid arthritis |
Q45024211 | The natural history of rheumatoid arthritis over 20 years. Clinical symptoms, radiological signs, treatment, mortality and prognostic significance of early features |
Q33554543 | The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up |
Q41038057 | The underestimated long term medical and economic consequences of rheumatoid arthritis. |
Q70303813 | Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective |
Q39701514 | Vasculitis and ulceration in rheumatic diseases of the foot |
Q39609243 | What happens to patients with rheumatoid arthritis? The long-term outcome of treatment |
Q37117517 | Worldwide trends in the socioeconomic impact and long-term prognosis of rheumatoid arthritis |
Q70744513 | [Glomerular nephropathies in untreated rheumatoid arthritis. Review of the literature apropos of 2 cases] |
Search more.